Last summer, Philips Respironics recalled millions of breathing devices, including ventilators, BiPAP and CPAP machines, citing a foam breakdown that can be accidentally inhaled. The FDA later labeled the recall with a class 1 sticker — the most serious type of recall because of the possibility of “death or serious injury” — and has reported 124 deaths “associated with the PE-PUR foam breakdown or suspected foam breakdown” since April 30.
People such as Rochester, N.Y., resident Diane Coleman have continued to use their machines: “It’s not like I can stop using it,” she told the LA Times.
A Philips spokesperson said repairing and replacing the recalled products will continue through “the end of 2022,” the LA Times reported.
Read the full article here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.